Eikon Therapeutics Inc. Common Stock

EIKN | NASDAQ

$5.31

-$0.04 (-0.75%)

At close: Oct 30, 2026, 4:00 PM ET

$5.20

-$0.11 (-2.07%)

Pre-market: Nov 2, 2026, 6:37 AM ET

Fiscal Quarter Period Ending	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025 Dec 31, 2025	Q3 2025 Sep 30, 2025
Cash & Equivalents	143.01M	161.55M	104.9M	104.87M
Short-Term Investments	388.57M	351.03M	231.07M	270.99M
Long-Term Investments	7.85M	91.64M	n/a	n/a
Other Long-Term Assets	539K	556K	11.95M	10.69M
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	15.4M	16.92M	12.94M	14.64M
Total Current Assets	546.98M	529.5M	348.92M	390.5M
Property-Plant & Equipment	224.21M	229.13M	233.86M	241.15M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	232.59M	321.33M	245.82M	251.84M
Total Assets	779.57M	850.83M	594.73M	642.34M
Account Payables	6.56M	6.01M	681K	4.28M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	9.45M	9.74M	n/a	n/a
Other Current Liabilities	23.58M	18.11M	35K	58K
Total Current Liabilities	55.3M	45.06M	55.01M	44.39M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	15M	10M	1.17B	1.17B
Total Long-Term Liabilities	257.77M	255.09M	1.42B	1.4B
Total Liabilities	313.07M	300.16M	1.47B	1.45B
Total Debt	252.22M	254.83M	257.32M	240.73M
Book Value	466.5M	550.67M	-879.03M	-804.35M
Book Value Per Share	8.62	10.17	-16.24	n/a
Common Stock	5K	5K	n/a	n/a
Retained Earnings	-1.09B	-1B	-920.51M	-840.85M
Comprehensive Income	n/a	n/a	n/a	n/a
Shareholders Equity	466.5M	550.67M	-879.03M	-804.35M
Total Investments	396.41M	442.66M	231.07M	270.99M